DPP-4 inhibitors can cause severe adverse effects such as hypersensitivity reactions (Stevens–Johnson syndrome, anaphylaxis, bullous pemphigoid), infections, pancreatitis or intestinal obstruction. The gene discussed is DPP4; the disease is intestinal obstruction.